Stockscreener 앱 받기
3.74
1.58%
-0.06
시간 외 거래:
3.74
전일 마감가:
$3.80
열려 있는:
$3.81
하루 거래량:
494.59K
Relative Volume:
2.60
시가총액:
$187.48M
수익:
$81.06M
순이익/손실:
$-55.55M
주가수익비율:
-2.5616
EPS:
-1.46
순현금흐름:
$-47.98M
1주 성능:
-18.52%
1개월 성능:
-37.35%
6개월 성능:
-29.96%
1년 성능:
+66.22%
1일 변동 폭
$3.65
$3.83
1주일 범위
$3.65
$4.56
52주 변동 폭
$2.17
$8.45
Sight Sciences Inc Stock (SGHT) Company Profile
명칭
Sight Sciences Inc
전화
(415) 889-0550
주소
4040 CAMPBELL AVE,, MENLO PARK
SGHT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| SGHT | 3.74 | 187.48M | 81.06M | -55.55M | -47.98M | -1.46 |
| ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
| SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
| BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
| MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
| EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-21 | 개시 | Lake Street | Buy |
| 2023-09-12 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-09-12 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2023-09-12 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-08-24 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-06 | 업그레이드 | Stifel | Hold → Buy |
| 2022-10-04 | 개시 | Needham | Hold |
| 2022-07-26 | 개시 | Stifel | Hold |
| 2022-02-03 | 개시 | William Blair | Outperform |
| 2022-01-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
모두보기
Sight Sciences Inc 주식(SGHT)의 최신 뉴스
Sight Sciences, Inc. (NASDAQ:SGHT) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Sight Sciences FY2024 EPS Estimate Raised by William Blair - MarketBeat
Sight Sciences Announces New Leadership Appointments - Vision Monday
Sight Sciences price target lowered to $5 from $7 at Morgan Stanley - Yahoo Finance
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates - MSN
Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $5.00 at Morgan Stanley - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Q3 2024 Earnings Call Transcript - Insider Monkey
Sight Sciences Reports Third Quarter Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - Vision Monday
Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Sight Sciences stock price target cut on Q3 revenue headwinds - Investing.com
Sight Sciences (NASDAQ:SGHT) Receives "Neutral" Rating from Piper Sandler - MarketBeat
Sight Sciences' (SGHT) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Sight Sciences stock price target cut on Q3 revenue headwinds By Investing.com - Investing.com UK
Sight Sciences Inc. (SGHT) PT Lowered to $5.50 at Piper Sandler - StreetInsider.com
Sight Sciences, Inc. (SGHT) Misses Q3 EPS by 1c - StreetInsider.com
Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Sight Sciences Reports Modest Growth and Optimistic Outlook - TipRanks
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations - The Manila Times
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - The Manila Times
Sight Sciences Appoints MK Raheja as Executive Vice - GlobeNewswire
Sight Sciences Strengthens Leadership: Ophthalmic Innovation Expert & Inogen Co-Founder Join Executive Team | SGHT Stock News - StockTitan
Sight Sciences Q3: Revenue Up 1%, Cash Flow Turns Positive Despite Mixed Results | SGHT Stock News - StockTitan
Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Lake Street cuts Sight Sciences stock rating to hold amid market challenges - Investing.com Canada
Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold - StreetInsider.com
Sight Sciences (NASDAQ:SGHT) Rating Lowered to "Hold" at Lake Street Capital - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight - The Malaysian Reserve
Sight Sciences (SGHT) Scheduled to Post Earnings on Thursday - MarketBeat
Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for - MSN
Microsoft Co. (NASDAQ:MSFT) Shares Acquired by Parametrica Management Ltd - Defense World
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Preview: Zynex's Earnings - Benzinga
Sight Sciences CCO Matthew Link sells $244,900 in stock - Investing.com India
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in Stock - MarketBeat
Sight Sciences CCO Matthew Link sells $244,900 in stock By Investing.com - Investing.com South Africa
The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World
The Manufacturers Life Insurance Company Buys New Position in Applied Optoelectronics, Inc. (NASDAQ:AAOI) - Defense World
The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
The Manufacturers Life Insurance Company Invests $123,000 in Lincoln Educational Services Co. (NASDAQ:LINC) - Defense World
The Manufacturers Life Insurance Company Invests $102,000 in Backblaze, Inc. (NASDAQ:BLZE) - Defense World
Sight Sciences' IPO Lock-up Period Ends On Jan 11 - RTTNews
This Insider Has Just Sold Shares In Sight Sciences - Simply Wall St
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 20,734 Shares - MarketBeat
Sight sciences' chief commercial officer sells shares worth $244,878 - Investing.com
Sight sciences' chief commercial officer sells shares worth $244,878 By Investing.com - Investing.com UK
KCK LTD. Reduces Stake in NeuroPace Inc - GuruFocus.com
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024 - The Manila Times
GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 - Yahoo Finance
Sight Sciences Inc (SGHT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.38%
0.43%
자본화:
|
볼륨(24시간):